HemoCue HGB High Level Control For HemoCue Glucose 201 & Hemoglobin 201+ 6Vl/Bx and 1 more item

The Florida Department of Health has awarded a contract valued at $1,413.00 with an award date of February 5, 2026, and a completion date of June 30, 2026. The contract encompasses the procurement of quality control materials for laboratory diagnostic equipment, specifically HemoCue glucose and hemoglobin analysis systems. The deliverables consist of two distinct product line items: ten units of HemoCue Hemoglobin High Level Control solution (6 vials per box) and ten units of HemoCue Hemoglobin Low Level Control solution (6 vials per box), each priced at $70.65 per unit.

These control materials are essential laboratory reagents used to verify the accuracy and reliability of HemoCue 201+ hemoglobin analyzers and HemoCue Glucose 201 systems prior to patient testing. The high and low level controls provide calibration verification across the measurement range, ensuring continued compliance with laboratory quality assurance standards. The contract period spans approximately five months, with delivery and completion obligations concluding on June 30, 2026. The prime contractor information and specific place of performance location were not disclosed in the award documentation provided.